Kohlberg Kravis Roberts & Co »

Cogent Biosciences shares owned by Kohlberg Kravis Roberts & Co

Quarter-by-quarter ownership of Cogent Biosciences shares owned by Kohlberg Kravis Roberts & Co from 13F filings

Historical chart of Kohlberg Kravis Roberts & Co investment in Cogent Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Cogent Biosciences held by Kohlberg Kravis Roberts & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cogent Biosciences by Kohlberg Kravis Roberts & Co

Quarter filed Position value Share count Share price at filing
2025-12-31 $1.2M 990k 1.18

More positions owned by Kohlberg Kravis Roberts & Co

Brightspring Health Svcs (BTSG)
Henry Schein (HSIC)
Bridgebio Pharma (BBIO)
Niq Global Intelligence Ordinary Shares (NIQ)
Brightview Holdings (BV)
Crescent Energy Company Cl A Com (CRGY)
Paramount Skydance Corp Com Cl B (PSKY)
Jetblue Airways Corp Note 0.500% 4/0 (Principal)
Kkr Real Estate Finance Trust (KREF)
Madison Square Grdn Sprt Cor Cl A (MSGS)
Seagate Hdd Cayman Note 3.500% 6/0 (Principal)
Bausch Health Companies (BHC)
Cable One Note 3/1 (Principal)
Northern Oil & Gas Note 3.625% 4/1 (Principal)
Immunocore Hldgs Note 2.500% 2/0 (Principal)

View all positions for Kohlberg Kravis Roberts & Co

Top funds holding Cogent Biosciences

Linden Advisors
Ing Investment Management
D. E. Shaw & Co
Wolverine Asset Management
Sona Asset Management
Calamos Advisors
Lord, Abbett & Co
Jump Financial
Oaktree Capital Management
Polar Securities
Ameriprise Financial
Readystate Asset Management
Polar Capital Holdings
Balyasny Asset Management
SSI Investment Management

View all funds holding Cogent Biosciences